A / B influenza virus antigen detection kit (colloidal gold method)
Item #: AM-COR-0591-ZP
Regulatory Status: Approved by Regulations on the Supervision and Administration of Medical Devices.
Test specimen: throat swab
Technical principle: fluorescence immunochromatography
Packaging specifications: 20 servings / box
Validity: 18 months
Applicable instrument: fluorescence chromatography test paper reader
Application: Clinical, fever, emergency detection
Disease control system influenza sentinel surveillance, outbreak field rapid screening
Preliminary Screening for Influenza A / B
Risk assessment for influenza A / B
High-risk population, newborn flu screening
Features: Pioneer: the first influenza virus detection product developed based on fluorescent nanotechnology, the country's leading technology
Convenience: It can be used for on-site testing, which is convenient for emergency, outpatient, community hospitals, and grassroots hospitals.
Fast: Single sample detection in 15 minutes
High sensitivity: 10-100 times more sensitive than colloidal gold detection technology
Strong specificity: Does not cross-react with other respiratory pathogens and other subtypes
Good stability: intra- and inter-assay differences <5%
VG55 Non-invasive Ventilator, Aeonmed, povide ICU-level non-...
Add to cart
Antu fully automatic blood culture system uses advanced non-...
Add to cart
As a professional supplier of medical devices, STEMart-PPE is good at listening, digging and uncovering the unique demands of our customers and committed to providing tailored solutions and products across the continuum of care. Through the power of science, we bring improvement to large healthcare systems, independent physician practices and daily life of home health patients and their families.
